No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract: Plasma Epstein-Barr virus DNA may have prognostic value for patients with nasopharyngeal carcinoma

byTeddy Guo

June 10, 2021

in StudyGraphics

Reading Time: 1 min read

Click to read the study in Clinical Cancer Research.

RELATED REPORTS

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy

#VisualAbstract: 3-Year Structured Exercise after Adjuvant Chemotherapy Improved Survival for Colon Cancer

#VisualAbstract: High-dose methylprednisolone vs. dexamethasone for COVID-19 pneumonia

RelatedReports

Age and breast cancer risk factors associated with false-positive mammography results

Chronic Disease

The addition of a carboplatin to standard of care adjuvant chemotherapy improves survival outcomes in patients with high-risk, early-stage triple-negative breast cancer

January 12, 2026

Selpercatinib may provide an effective response against RET-mutated thyroid cancer

Chronic Disease

Postoperative radioiodine ablation does not reduce cancer recurrence following thyroidectomy

July 31, 2025

StudyGraphics

#VisualAbstract: 3-Year Structured Exercise after Adjuvant Chemotherapy Improved Survival for Colon Cancer

August 7, 2025

StudyGraphics

#VisualAbstract: Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer

July 9, 2025

#VisualAbstract Cutaneous reactions in children treated with MEK and/or BRAF inhibitors are common and often lead to interruptions or alterations in chemotherapy

Ziltivekimab antagonism of IL-6 reduces inflammation and thrombosis in patients with atherosclerotic risk factors

Wellness Check: Mental Health

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result